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Abstract P2X receptors for ATP comprise a distinct fam-
ily of ligand gated ion channels with a range of proper-
ties. They have been shown to be involved in a variety of
physiological processes including blood clotting, sensory
perception, pain sensation, bone formation as well as
inXammation and may provide a number of novel drug tar-
gets. In addition to the orthosteric site for ATP binding it
has been suggested that there may be additional allosteric
sites that regulate agonist action at the receptor. There is
currently no crystal structure available for P2X receptors
and the lack of sequence similarity to other ATP binding
proteins has meant that a mutagenesis-based approach has
been used primarily to investigate receptor structure-func-
tion. This review aims to provide an overview of recent
work that gives an insight into residues involved in ATP
action and allosteric regulation.
Keywords P2X receptor · ATP · Allosteric · Structure-
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P2X receptors and ATP action
P2X receptors comprise a distinct family of ligand gated
cation channels. Genes encoding seven P2X receptor sub-
uints (P2X1–7) have been cloned and they form as homo-
and heterotrimeric receptors with a range of properties
(North 2002). ATP binds to the extracellular loop of the
P2X receptors and it has been suggested that three mole-
cules of agonist are required to bind and open the ion chan-
nel (Bean 1990; Ding and Sachs 1999). P2X receptors do
not contain consensus sequences for agonist binding that
have been identiWed in other ATP sensitive proteins, e.g.
the Walker motif (Walker et al. 1982). This suggests that
the P2X receptors have a novel ATP binding site. The
extracellular loop contains »280 amino acids and greater
than 90 of these residues are conserved in at least Wve of the
seven mammalian P2X receptor subunits. The contribution
of the majority of these conserved amino acids has been
studied using alanine scanning mutagenesis. In systematic
studies on the human P2X1 receptor the roles of conserved
charged (Ennion et al. 2000, 2001), aromatic (Roberts and
Evans 2004), structural (Ennion and Evans 2002; Digby
et al. 2005; Roberts and Evans 2005) and polar amino acids
(Roberts and Evans 2006) have been studied (for a review
see Vial et al. 2004; Roberts et al. 2006). This work has
shown that the majority of individual alanine substitutions
have little or no eVect on ATP potency at the receptor, how-
ever for a small number of the mutant receptors there was a
large decrease in ATP sensitivity (Fig. 1). A similar picture
emerges from alanine mutagenesis of conserved charged
and polar residues at P2X2 receptors (Jiang et al. 2000).
These studies have allowed for the generation of a model of
the ATP binding site (P2X1 receptor numbering). It has
been proposed that the negatively charged phosphate group
of ATP is co-ordinated between positively charged lysine
residues K68, K70 and K309 and the adenine ring may be
sandwiched between two aromatic regions F185T186 and
N290F291R292 (Roberts et al. 2006) (Fig. 2).
The model has been supported by two recent cysteine
mutagenesis studies (Marquez-Klaka et al. 2007; Roberts
and Evans 2007). Using a scanning approach the contribu-
tion of the 44 amino acids before the second transmem-
brane domain of the P2X1 receptor was determined
(Roberts and Evans 2007). This work showed that in this
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reduced ATP potency and this was also reXected in a
decrease in binding of radiolabelled 2-azidoATP. However
it was clear from comparing the eVects on the extent of the
decrease in ATP potency with the eVects on 2-azido ATP
binding that there were likely to be eVects on both agonist
binding and the gating of the channel for some of these
mutants. A recent study using single channel recordings
from P2X2 receptor mutants has suggested that for the
P2X2 receptor K308 also contributes to channel gating (Cao
et al. 2007). ModiWcation of the cysteine mutants in the
P2X1 receptor with thiol reactive methanethiosulphonate
reagents produced additional shifts in ATP potency consis-
tent with a contribution of these residues to ATP binding
(Roberts and Evans 2007). The fact that there was little or
no change in ATP potency at the other 40 cysteine mutants
studied in this region further highlights the importance of
these residues in mediating ATP action.
Marquez-Klaka et al. (2007) also used a cysteine muta-
genesis approach to look at the contribution of residues
suggested to form the ATP binding site. They reported sim-
ilar changes in ATP potency from mutants of the rat P2X1
receptor and in chimaeric rat P2X2–1 receptors. They then
tested whether any of these cysteine substituted residues
were close enough to form a disulphide bond. They found
that K68C and F291C mutants could form a disulphide
bond, and that this bond formation was inhibited by ATP
(Marquez-Klaka et al. 2007) providing some molecular
dimensions for the proximity of these residues. Taken
together these cysteine mutagenesis studies provide strong
evidence that K68, F291 and K309 are intimately involved
in determining ATP action at the receptor, most likely as
forming the agonist binding site.
One of the ongoing questions about the ATP binding site
has been whether it is formed within or between subunits.
The Wrst experimental evidence to support that ATP action
was co-ordinated between subunits was provided by Wil-
kinson et al. (2006). They co-expressed WT and alanine
substitution mutants of the lysine residues equivalent to
K68 and K309 (P2X1 receptor numbering). This work
Fig. 1 Summary of mutagenesis data for P2X receptors. The sequence
corresponding to the extracellular domain and parts of the adjacent
transmembrane domains (TM1 and TM2) of the human P2X1 receptor
is shown. The ten conserved cysteine residues are shown in black. Con-
served residues that when mutated to alanine or cysteine have a signiW-
cant eVect on ATP potency shown in orange and underlined. Purple
residues correspond to where alanine substituion of conserved aro-
matic residues gave rise to non-functional channels. Alanine or cyste-
ine mutants of the human P2X1 receptor that had no or <10 eVect on
ATP potency are shown as dashed grey lines. Residues in khaki corre-
spond to those in other P2X receptor subunits that when mutated have
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Fig. 2 Model of the proximity of the orthosteric and cysteine rich allo-
steric binding sites at P2X receptors based on mutational analysis. The
putatitive orthosteric ATP binding site incorporating K68, K70, F185,
N290, F291, R292 and K309 identiWed from mutagenesis studies based
on a model of synpasin II is shown (Roberts and Evans 2007), it is like-
ly that the residues K68 and K70 are contributed from an adjacent sub-
unit giving rise to an inter subunit binding site (Marquez-Klakaet al.
2007). The cysteine (black circles) rich allosteric sites are shown (not
to scale), the numbers correspond to the order of the conserved cyste-
inesin the extracellular loop with predicted disulphide bonds (indicated
by black dotted lines) in the pairings 1–6, 2–4, 3–5 and 7–8. The cys-
teine rich regions 1–6 and 7–8 are in adjacent P2X receptor subunits as
suggested by the disulphide bond (indicated by khaki dotted line) that
can be formed between cysteine substitution mutants for histidines120
and 213 in the P2X2 receptor (Nagaya et al. 2005). Other residues that
when mutated have eVects on allosteric regulation are shown as khaki
circles. The residue in pink corresponds to the arginine residues at the
P2X7 receptor that can be ADP ribosylated and leads to activation of
the channel (Adriouch et al. 2007), the red dotted line indicates the









Eur Biophys J (2009) 38:319–327 321suggested that the P2X2/3 heteromeric channel contains one
P2X2 and two P2X3 receptor subunits, and that residues
from two diVerent subunits interact to regulate ATP bind-
ing and/or channel gating (Wilkinson et al. 2006). The
work of Marques-Klaka et al. (2007) also provides struc-
tural support for the idea that the interface between subunits
is important for regulating ATP action as the disulphide
bond that they showed could form between K68C and
F291C was between adjacent subunits.
There was some suggestion that P2X receptors may not
share a common ATP binding site as P2X4 receptors muta-
genesis studies support other amino acids in the second half
of the extracellular domain that are important for determin-
ing ATP sensitivity and are consistent with an agonist bind-
ing site based on sequence similarity to the family of tRNA
synthetases (Stojilkovic et al. 2005; Yan et al. 2005). How-
ever more recent work has also shown that the residues pre-
dicted from the P2X1 receptor model show similar eVects at
P2X4 receptors (Zemkova et al. 2007). This suggests that
there may be a core ATP binding site that is common to
P2X receptors but there are subtype speciWc diVerences that
would be consistent with the diVerences in pharmacological
properties between the receptors.
The functional expression of a P2X receptor channel
from the amoeba Dictyostelium discoideum (DdP2X) has
provided some interesting insight into the modelling of the
receptors (Fountain et al. 2007). Many residues that are
conserved across the mammalian and Schistosome P2X
receptors are absent from the DdP2X receptor (Fountain
et al. 2007) however four of the seven residues proposed to
be part of the mammalian P2X receptor are totally con-
served and at one other position there is a conservative sub-
stitution (K70, F185, T186, K309 and F291 respectively
P2X1 receptor numbering). Positive charges equivalent to
K70 and K309 in the P2X1 receptor are conserved in the
DdP2X receptor and when mutated to alanine result in a
decrease in ATP potency as found in a range of P2X recep-
tors (Ennion et al. 2000; Jiang et al. 2000; Wilkinson et al.
2006; Zemkova et al. 2007) consistent with the proposed
role of these charged residues in co-ordinating the nega-
tively charged phosphate of ATP. The N290F291R292
motif (P2X1 receptor numbering) that is totally conserved
throughout mammalian and the Shistosoma P2X receptors
is absent from DdP2X (Fountain et al. 2007). However
there is a conserved tyrosine residue at an equivalent posi-
tion to the phenylalanine in the whole family of DdP2Xs
suggesting that there is always an aromatic amino acid at
this position. It is interesting that it is the equivalent phen-
ylalanine residue (F291) in the P2X1 receptor that has been
shown to be close to K68 in an adjacent subunit by cysteine
substitution and disulphide bond analysis (Marquez-Klaka
et al. 2007) and that formation of this bond is blocked by
ATP binding. It will be interesting to determine whether the
tyrosine of the DdP2X plays an equivalent role in mediat-
ing ATP action.
The other residues F185T186 (P2X1 receptor number-
ing) that have been suggested to form part of the ATP bind-
ing site are also conserved in the DdP2X however the
alanine replacement of the conserved phenyalanine had lit-
tle or no eVect on ATP sensitivity suggesting that it does
not play an essential role in agonist action. At the P2X1
receptor the equivalent alanine mutation only gives rise to a
modest »10-fold decrease in ATP potency suggesting that
the aromatic residues does not make a major contribution to
agonist sensitivity, however the eYcacy of the partial ago-
nists BzATP and Ap5A were essentially abolished at this
mutant (Roberts and Evans 2004). This is the same as that
seen for the P2X1 receptor mutants K68A, F291A, R292A
and K309A (Roberts and Evans 2004) that have been
widely suggested to contribute to the ATP binding site. The
conserved neighbouring threonine when mutated to alanine
(T186A) decreased ATP potency at the P2X1 receptors by
six fold and abolished the eYcacy of BzATP and Ap5A
(Roberts and Evans 2006) and at P2X2 receptors the T186A
mutant reduced ATP potency by » 100 fold (Jiang et al.
2000). These mammalian studies suggest that the
F185T186 region plays a role in the regulation of agonist
action at P2X receptors although it remains to be deter-
mined directly whether this results from an eVect on agonist
binding or gating of the channel. The eVects of the partial
agonists on the equivalent F-A and T-A mutants in recep-
tors other than P2X1 have yet to be determined and would
provide insight into the conservation of the role of this
region throughout the receptor family.
The pharmacology of the P2X receptor also raises some
interesting questions about the agonist binding site. If there
were a simple agonist binding pocket one might suppose
that ADP would have some aYnity for the site however at
the P2X1 receptor it is ineVective as either an agonist or
antagonist (Mahaut-Smith et al. 2000; Vial et al. 2003).
These Wndings suggested that compared to the binding of
the adenine ring or ribose the detection/co-ordination of the
three phosphate residues plays a dominant role in determin-
ing the aYnity of drugs at the agonist binding site. It is
interesting that longer chain phosphates also activate the
channel with for example adenosine tetraphosphate and the
diadenosine polyphosphate Ap5A acting as agonists (Lewis
et al. 2000). This suggests that the structure of the binding
site that recognises the phosphate tail of ATP is relatively
open-ended and can accommodate additional substitutions
i.e. in the case of Ap5A essentially an ADP molecule bound
to the end of ATP. The idea that the binding site can
accommodate substitutions at the end of the phosphate tail
is also supported by studies shown that the P2X7 receptor
can be activated following ADP-ribosylation (Seman et al.
2003). Recent studies have shown that the P2X7 can be post123
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syltransferases that transfer ADP-ribose from NAD onto
arginines 125 and 133 and that it is the ribosylation of argi-
nine 125 that is suYcient to activate the receptor (Adriouch
et al. 2007). At P2X7 receptors ADP is ineVective as an
agonist (Adriouch et al. 2007). Adriouch et al. (2007)
suggest that the ADP-ribosylation site is close to the ATP
binding site and the covalent tethering of ADP-ribose (the
ribose eVectively acting as a linker from the beta phosphate
of ADP) to arginine 125 allows the ADP molecule to now
bind at the receptor. This covalent binding would overcome
the usual low aYnity of ADP for the binding site and pre-
sumably allow the binding of the phosphates, ribose and
adenine to activate the receptor. The arginine residue is in a
cysteine rich domain (Fig. 2) that has been suggested to be
involved in zinc potentiation of P2X receptors (see later).
This work with the P2X7 receptor has provided additional
clues as to the molecular structure of the agonist binding
site and nearby regions of the receptor.
The functional response of P2X receptors to ATP con-
sists of the initial agonist binding step and then subsequent
conformational change associated with the opening of the
ion channel (the gating step). In the mutagenesis studies
that have been done on P2X receptors macroscopic currents
have been recorded and any changes in ATP potency could
arise from eVects on agonist binding and/or gating (Colqu-
houn 1998). A crystal structure would be needed to deWni-
tively prove the molecular basis of the ATP binding site.
However the balance of current evidence and opinion is
strongest that residues equivalent to K68 and K309 (P2X1
receptor numbering, that give the largest decreases in ATP
potency) are involved in ATP binding (for example it
would be unusual to have an ATP binding protein that did
not have positively charged residues involved in agonist
binding). Recent studies on mutants of the P2X2 receptor
have suggested that K308 also contributes to gating of this
channel (Cao et al. 2007). For some of the P2X receptor
mutants it is likely that the small changes ATP potency
result from modiWcation of the structure of the receptor or
the conformational gating changes. It is interesting that if
the proposed model of the ATP binding site is correct that
the agonist binds at some distance from the regions of the
receptor that form the ion conducting pore as seen for cys
loop and glutamate ion channels. For example residue
K309 is »20 amino acids away from the start of the second
transmembrane domain. Studies on this possible linker
region have suggested that it can play a role in the transduc-
tion of agonist binding to channel gating (Yan et al. 2006;
Roberts and Evans 2007) and there is evidence from
changes in the pattern of MTSEA-biotinylation of intro-
duced cysteine residues that this region undergoes confor-
mational changes on ATP binding (Roberts and Evans
2007).
Overall these studies support a model where ATP action
is co-ordinated by positively charged lysine residues inter-
acting with the negatively charged phosphate tail of ATP
and it seems likely the adenine ring is co-ordinated by aro-
matic phenylalanine residues. Whether there are residues
that interact directly with the ribose moiety remain to be
determined. The mutagenesis studies suggest that P2X
receptors share a broadly similar agonist binding pocket,
however there are likely to be some variations in the local
binding environment or gating movements to account for
the diVerences in agonist sensitivity between receptor sub-
units.
Regulatory sites
In addition to the orthosteric agonist binding site many
receptors have additional allosteric binding sites that may
regulate the activity of the receptor. For example the aYn-
ity of GABA binding to GABAA receptors can be increased
by benzodiazepine binding to a distinct allosteric site. It is
now clear that the potency of ATP at P2X receptors may
also be regulated by similar allosteric mechanisms. For
example sub-maximal P2X receptor currents recorded from
nodose, sympathetic and spinal cord neurons (Cloues et al.
1993; Li et al. 1993) were potentiated by low concentra-
tions (<10 M) of zinc. The eVect was due to a left shift in
the concentration response to ATP with no change in the
maximal response (Cloues et al. 1993; Li et al. 1993), these
characteristics and single channel analysis showing that
zinc increased opening frequency and burst duration (Clo-
ues 1995) are consistent with low concentrations of zinc
acting as an allosteric modulator. Subsequent studies
addressed the subtype sensitivity to zinc modulation and
showed that P2X2 and P2X4 receptor currents could be
increased by low micromolar concentrations of zinc (Brake
et al. 1994; Seguela et al. 1996; Soto et al. 1996; Xiong
et al. 1999) while P2X1 (Wildman et al. 1999) and P2X7
receptor currents were decreased (Virginio et al. 1997).
Further studies have shown that P2X receptor currents can
be regulated by other ionic species including copper (Xiong
et al. 1999) as well as protons (King et al. 1996; Li et al.
1996; Stoop et al. 1997; Wildman et al. 1998, 1999) and the
sensitivity to ionic regulation can be used, in part, to assign
molecular P2X receptor subtypes to native receptors (Wild-
man et al. 1999; North and Surprenant 2000).
The molecular basis of the sites of regulation by metals
and pH has been investigated in a number of mutagenesis
studies on P2X receptor subtypes. Histidine residues were
considered most likely to be involved in these eVects as the
sensitivity of charge at this residue to pH makes it a candi-
date for regulation by protons and histidines have also been
found as part of the metal binding pockets for both copper
and zinc (Richardson et al. 1975; Aitken 1999; Vallee et al.123
Eur Biophys J (2009) 38:319–327 3231999). However the lack of conserved histidine residues in
the extracellular domain of the P2X receptor family sug-
gested that there was not a common site of regulation.
Analysis of mutagenesis studies on a range of P2X recep-
tors provides an emerging picture of the molecular basis of
allosteric sites (Table 1).
P2X2 receptors
P2X2 receptor currents can be potentiated by pH and low
micromolar concentrations of zinc by an apparent allosteric
eVect. Alanine point mutations of seven of the conserved
ten cysteine residues in the extracellular domain almost
abolished the positive allosteric eVects of zinc and indicate
that these residues play an important role in zinc action.
These mutants also reduced ATP potency at the receptor
and it was suggested that the cystiene residues may form
disulphide bonds and that the breaking of these bonds
resulted in structural changes that can account for the
reduced eVects of zinc (Clyne et al. 2002a). The suggestion
that the cysteine residues may form disulphide bonds was
also supported by work on P2X1 receptors (Ennion and
Evans 2002). At the P2X1 receptor MTSEA-biotin does not
label wild type P2X1 receptors showing that all the cystiene
residues are disulphide-bonded or inaccessible. Mutation of
cysteines 126, 132, 149, 159, 217 or 227 resulted in label-
ling of the receptor with MTSEA-biotin indicating the
exposure of a free cysteine residue created by the disruption
of a disulphide bond and this work provides biochemical
evidence to suggest at least three disulphide bonds (Ennion
and Evans 2002). These results indicate that the disulphide
bonding may be essential for the formation of a metal bind-
ing pocket (Clyne et al. 2002a; Ennion and Evans 2002)
however direct conWrmation for the predicted disulphide
bonds remains to be provided.
Histidine residues have been shown to contribute to allo-
steric binding sites in the P2X2 receptor. Potentiation of
P2X2 responses by low micromolar zinc was abolished for
either of the two mutants H120A and H213A (Clyne et al.
2002b; Lorca et al. 2005) (however the inhibitory eVects of
higher concentrations zinc were preserved for these mutants
demonstrating the complex nature of zinc action). In subse-
quent studies cysteine mutants of H120 and H213 were gen-
erated and shown to form a disulphide bond between
adjacent subunits (Nagaya et al. 2005). This was a very
important Wnding and provided not only evidence that the
zinc binding site forms at the interface between subunits but
also some molecular distances within the P2X receptor. It is
also interesting to note that these histidine residues are close
to conserved cysteine residues and as suggested above disul-
phide bonds could stabilise the zinc binding site (Fig. 2).
Using chimeras the study also showed that the level of zinc
potentiation was dependent on the number of functional
intersubunit zinc binding sites (Nagaya et al. 2005). Subse-
quent work has suggested the region around the zinc binding
site is moderately Xexible (Tittle et al. 2007).
A distinct histidine residue has also been shown to con-
tribute to the pH sensitivity of the P2X2 receptor. The
mutant H319A results in a decrease in pH sensitivity of the
receptor (with no eVect on zinc sensitivity) and in contrast
to WT receptors the peak current was reduced when the pH
was changed from pH 7.5 to 6.5 (Clyne et al. 2002b). The
contribution of H319 as a proton sensor was also tested by
making the H319K mutation to mimic the eVects of proton-
ation of the histidine. The ATP potency of the H319K
mutant was increased »40-fold consistent with protonation
of H319 playing a central role in pH regulation of the chan-
nel (Clyne et al. 2002b). It is interesting that this residue is
in a region that has been suggested to be part of a linker
region connecting the ligand binding domain to the channel
pore (Yan et al. 2006; Roberts and Evans 2007) and proton-
ation of H319 could play a role in regulation of gating of
the channel that could account for the positive allosteric
eVect on ATP potency.
P2X3 receptors
P2X3 receptors are sensitive to pH with acidiWcation reduc-
ing the amplitude of evoked currents at an EC50 concentra-
tion of agonist (Stoop et al. 1997). AcidiWcation also leads
to a slowing in the time-course of P2X3 receptor currents
and resulted in a depression of currents evoked by low con-
centrations of agonist but facilitated currents in response to
high agonist concentrations and decreased ATP potency
(Gerevich et al. 2007). Interestingly acidiWcation also short-
ened the time required for the P2X3 receptor to recover
from desensitisation with the time for 50% recovery from
the fully desensitised state speeding from »1 min at pH 7.4
Table 1 Mutants that aVect ionic sensitivity/regulation (see text for details)
Zinc Copper pH
P2X2 H120, H213 H120, H213 H319
P2X3 H206
P2X4 C132, T133 (increased by D131, D138, H140) D129, D138, H140 H286
P2X7 (oocytes) H62, D197, H201, H267 (HEK) H219, H267 (oocytes) H62, D197, H201, H267 (HEK) H130, 
H201, H267 (oocytes)
H130123
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H206A abolished the pH dependent eVect on the maximum
response as well as the time course and reduced the
decrease in agonist potency from pH 7.4 to 5.8 from »4-
fold to »2-fold. This residue in the P2X3 receptor is close
(5–10 residues) to the conserved FT region (185–186 P2X1
receptor numbering) that has been suggested to be involved
in ATP action (Roberts et al. 2006) and also K190 that
reduced ATP potency at both P2X1 and more dramatically
at P2X2 receptors (Ennion et al. 2000; Jiang et al. 2000).
The mutation in the Wrst transmembrane domain H45A had
no eVect on the potentiation of the maximum response but
produced a greater decrease in ATP potency (Gerevich
et al. 2007). Previous studies have shown that mutations
within the transmembrane domains can change agonist
potency most likely through an eVect on channel gating.
P2X4 receptors
At rat PX4 receptors 10 M zinc produced a modest »3-
fold increase in ATP potency at the receptor with no eVect
on the maximum response to ATP or the Hill coeYcient
(Acuna-Castillo et al. 2000). In contrast copper (300 M)
had no eVect on the ATP sensitivity but reduced responses
by »60% (Acuna-Castillo et al. 2000). The eVects of zinc
were instantaneous whereas those of copper took time to
develop. Site directed mutagenesis has been used to investi-
gate the molecular basis of the action of copper and zinc at
the P2X4 receptor. These studies have shown that alanine
mutation of either H140 or D138 abolished inhibition by
copper (Coddou et al. 2003, 2007). Interestingly these ala-
nine mutations also increased the potentiation by zinc by 2–
4-fold. These results suggest there may be some overlap
in the residues that mediate the actions of zinc and copper
(or that zinc may have sites that mediate both positive and
negative eVects—although it is clear that they are close
together and associated with the cysteine rich region,
Fig. 2). In addition alanine mutation of D129 reduced the
extent of copper inhibition but had no eVect on the eVects
of zinc (Coddou et al. 2007).
Recent work on the P2X4 receptor identiWed residues
associated with zinc potentiation at the receptor. The facili-
tatory eVects of zinc were abolished for the C132A mutant
(but not C126A) and signiWcantly reduced for the mutant
T133A, however neither of these mutants had an eVect on
the inhibition by copper (Coddou et al. 2007). In additional
experiments they showed that MTSET that had no eVect on
ATP responses but reduced by »50% the potentiation by
zinc, and the authors suggest that this results from modiW-
cation of C132. Taking these results together Coddou et al.
suggest that the C132 residue is not exclusively involved in
disulphide bonding but that it contributes to the zinc
binding site. For the P2X1 and P2X2 receptors it has been
suggested that the cysteine residue 132 forms a disulphide
bond with residue cysteine 159 (both P2X1 and P2X4 num-
bering) (Clyne et al. 2002a; Ennion and Evans 2002). At
P2X2 receptors alanine mutation of seven of the conserved
cysteine residues (including the equivalents of C126 and
C132 in the P2X4 receptor) reduced zinc potentiation and it
was suggested these eVects resulted from structural altera-
tions in the receptor due to the breaking of disulphide bonds
(see above). This raises the possibility that the C132A
mutation in the P2X4 receptor leads to the breaking of a
disulphide bond (predicted with C159, and the eVects of the
C159A mutant were not tested) and this changes the struc-
ture of the protein and removes the zinc modulatory site.
Support for the free cysteine at position 132 in the P2X4
receptor was also suggested from the eVects of MTSET on
zinc potentiation (Coddou et al. 2007). At P2X2 receptors
that are potentiated by zinc MTSET has no eVect (Clyne
et al. 2002a) on WT channels. However MTSET reduced
zinc potentiation at cysteine mutants of H120 and H213
that have been shown to be involved in zinc regulation at
the P2X2 receptor (Nagaya et al. 2005). This suggests that
MTSET can access and partially block the zinc binding site
of P2X2 receptors and suggests that any cysteine residues in
the WT receptor are unavailable for modiWcation either as
they are part of a disulphide bond or are deep in the zinc
binding site. MTSET can also permeate through P2X recep-
tor channels (Rassendren et al. 1997) and blocks currents at
P2X2 receptors with cysteine substitution mutations at posi-
tions D15 and P19 (Jiang et al. 2001). Splice variants of
P2X receptors and mutational studies have indicated that
the intracellular domains of the receptor can regulate the
gating of P2X receptor channels. There are a number of
cysteine residues in the intracellular domains of the P2X4
receptor and this raises the possibility that these residues
could contribute to the regulatory eVects of MTSET. How-
ever what is clear from these studies is that the cysteine rich
region plays a role in zinc regulation.
P2X4 receptors are also sensitive to regulation by
changes in pH with acidiWcation inhibiting ATP evoked
responses (Stoop et al. 1997; Clarke et al. 2000). At the rat
P2X4 receptor the histidine 286 to alanine mutation had no
eVect on regulation by copper or zinc (Coddou et al. 2003)
however in the human receptor it abolished the sensitivity
to protons (Clarke et al. 2000). Interestingly this is close to
the NFR motif that we have shown to be involved in ATP
action/binding at the receptor.
P2X7 receptors
Agonist evoked P2X7 receptor currents are inhibited by
both zinc and copper (Virginio et al. 1997). The site(s) of
action of zinc and copper have been determined in muta-
genesis studies (Acuna-Castillo et al. 2007; Liu et al.123
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at the eVects of mutation of histidine, glutamate, aspartate
and lysine residues. However the eVects of some of the
mutations appeared to be dependent on the expression
system or the agonist used. When expressed in Xenopus
oocytes (Acuna-Castillo et al. 2007) ATP evoked currents
at the mutant H267A was unaVected by copper and zinc,
H201A and H130A had reduced sensitivity to copper and
H219A was less sensitive to zinc inhibition. H201A and
H130A were also shown to be involved in magnesisum
inhibition of P2X7 receptor currents (Acuna-Castillo et al.
2007). In studies with HEK293 cells a diVerent pattern was
seen on ATP evoked responses (Liu et al. 2008), H62A and
D197A reduced inhibition by copper or zinc and the double
mutant H62AD197A abolished the inhibitory eVects of
these metals [the H62A mutant showed no change in sensi-
tivity to copper or zinc compared to wild type in oocyte
studies and the reason for the diVerence in sensitivity
between the expression systems remains to be determined
(Acuna-Castillo et al. 2007)]. H201A, and H267A had a
small eVect on copper or zinc inhibition (however when
BzATP was used as the agonist the inhibitory eVects of
copper and zinc at these mutants and wild type P2X7 recep-
tors were indistinguishable) (Liu et al. 2008). The consen-
sus for ATP action is that H201A and H267A can be
involved in regulation by copper although the relative eVect
of these mutation appears to be dependent on the expres-
sion system.
The diVerential sensitivity of P2X receptors to regulation
by zinc and pH is supported by the mutagenesis studies
summarised above that show that there is no consensus in
the amino acids involved in regulation and this is consistent
with the lack of conservation of residues at these positions.
For residues suggested to be involved in pH regulation of
P2X2,3,4,7 receptors there appears to be no pattern emerging
from the diVerent subunits and this suggests that pH regula-
tion may not have a common basis and be subunit speciWc
(Table 1). However a pattern appears to emerge when con-
sidering some of the residues associated with zinc sensitiv-
ity where several residues identiWed from P2X2 and P2X4
receptors appear to be clustered around the cysteine rich
region corresponding to the Wrst three conserved cysteine
residues (Fig. 2). This cystiene rich region includes the
lysine residue that has been shown to be ADP ribosylated in
P2X7 receptors and has been suggested to be close to the
ATP binding site (Adriouch et al. 2007 see above). This
provides some evidence that the zinc allosteric site and the
ATP binding site may be in close proximity as had been
postulated previously (Tittle et al. 2007). Studies on the
P2X2 receptor have shown that it is likely that the residues
H120 and H213 from adjacent subunits are close enough
together that when they are substituted for cysteine they can
form a disulphide bond (Nagaya et al. 2005). This suggests
that there is a cysteine rich region (formed from two adja-
cent subuntis) associated with zinc regulation and is consis-
tent with studies on the P2X2 receptor that showed that zinc
potentiation was almost abolished when any of the Wrst
seven cysteine residues was mutated to alanine. It is inter-
esting that in the Dictyostelium P2X receptor only cysteine
residues corresponding to cysteines 1 and 6 in the mamma-
lian P2X receptors are conserved and the cysteine rich
region of »46 residues that contains cysteines 2, 3, 4 and 5
as well as residues involved in zinc potentiation is absent.
However from the prediction based on mutagenesis studies
of P2X1 and P2X2 receptors the conserved cysteines 1 and
6 of mammalian receptors that are predicted to form a
disulphide bond are present (and correspond to cysteines 3
and 4 of the Dd P2X receptor), and could form a disulphide
bond to stabilise the Dictyostelium receptor.
Summary
Mutagenesis studies have clearly highlighted a number of
amino acids that play a key role in regulating ATP sensitiv-
ity and allosteric regulation by zinc and pH. Recent studies
have suggested that the ATP binding site and the cysteine
rich zinc regulatory site are close (Fig. 2). The introduction
of cysteine residues and the formation of disulphide bonds
suggests that both the ATP binding site and the zinc alloste-
ric site are formed at the interface between subunits. The
question that remains to be determined is which part of the
ATP site and the zinc site are on the same subunit. These
mutagenesis studies have given us considerable insight into
residues involved in ATP action at P2X receptors and have
allowed the development and reWnement of models. These
studies with disulphide bonding and the ADP ribosylation
have given us some molecular distances for the P2X recep-
tor subunits and will be useful for validation of any future
crystal structure that is produced of the receptor. In other
channels mutagenesis studies have generally been eVective
in predicting important information on the structure-func-
tion that have been supported by subsequent crystal struc-
tures. A crystal structure for the P2X receptor is eagerly
awaited and it is promising that recently a structure for an
acid sensing trimeric ion channel with two transmembrane
domains has been produced (Jasti et al. 2007).
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